Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)

NCT05860881 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Solid Organ Transplant Recipients
Skin Cancer

Interventions

DRUG: Sirolimus Topical Cream
OTHER: Placebo

Sponsor

Melanoma and Skin Cancer Trials Limited

Collaborators

[object Object]
[object Object]